Depression and congestive heart failure

Thomas P. Guck; Gary N. Elsasser; Michael G. Kavan; Eugene J. Barone

doi:10.1111/j.1527-5299.2003.01356.x

Depression and congestive heart failure

Thomas P. Guck, Gary N. Elsasser, Michael G. Kavan, Eugene J. Barone

Department of Family Medicine

Research output: Contribution to journal › Review article › peer-review

72 Scopus citations

Abstract

The prevalence rates of depression in congestive heart failure patients range from 24%-42%. Depression is a graded, independent risk factor for readmission to the hospital, functional decline, and mortality in patients with congestive heart failure. Physicians can assess depression by using the SIG E CAPS + mood mnemonic, or any of a number of easily administered and scored self-report inventories. Cognitive-behavior therapy is the preferred psychological treatment. Cognitive-behavior therapy emphasizes the reciprocal interactions among physiology, environmental events, thoughts, and behaviors, and how these may be altered to produce changes in mood and behavior. Pharmacologically, the selective serotonin reuptake inhibitors are recommended, whereas the tricyclic antidepressants are not recommended for depression in congestive heart failure patients. The combination of a selective serotonin reuptake inhibitor with cognitive-behavior therapy is often the most effective treatment.

Original language	English (US)
Pages (from-to)	163-169
Number of pages	7
Journal	Congestive Heart Failure
Volume	9
Issue number	3
DOIs	https://doi.org/10.1111/j.1527-5299.2003.01356.x
State	Published - 2003

All Science Journal Classification (ASJC) codes

Emergency Medicine
Emergency
Cardiology and Cardiovascular Medicine

Access to Document

10.1111/j.1527-5299.2003.01356.x

Fingerprint Dive into the research topics of 'Depression and congestive heart failure'. Together they form a unique fingerprint.

Cite this

@article{df3bbeaee52a4f7a9dc44579bcce1219,

title = "Depression and congestive heart failure",

abstract = "The prevalence rates of depression in congestive heart failure patients range from 24%-42%. Depression is a graded, independent risk factor for readmission to the hospital, functional decline, and mortality in patients with congestive heart failure. Physicians can assess depression by using the SIG E CAPS + mood mnemonic, or any of a number of easily administered and scored self-report inventories. Cognitive-behavior therapy is the preferred psychological treatment. Cognitive-behavior therapy emphasizes the reciprocal interactions among physiology, environmental events, thoughts, and behaviors, and how these may be altered to produce changes in mood and behavior. Pharmacologically, the selective serotonin reuptake inhibitors are recommended, whereas the tricyclic antidepressants are not recommended for depression in congestive heart failure patients. The combination of a selective serotonin reuptake inhibitor with cognitive-behavior therapy is often the most effective treatment.",

author = "Guck, {Thomas P.} and Elsasser, {Gary N.} and Kavan, {Michael G.} and Barone, {Eugene J.}",

year = "2003",

doi = "10.1111/j.1527-5299.2003.01356.x",

language = "English (US)",

volume = "9",

pages = "163--169",

journal = "Prevention and Management of Congestive Heart Failure",

issn = "1527-5299",

publisher = "Wiley-Blackwell",

number = "3",

}

TY - JOUR

T1 - Depression and congestive heart failure

AU - Guck, Thomas P.

AU - Elsasser, Gary N.

AU - Kavan, Michael G.

AU - Barone, Eugene J.

PY - 2003

Y1 - 2003

N2 - The prevalence rates of depression in congestive heart failure patients range from 24%-42%. Depression is a graded, independent risk factor for readmission to the hospital, functional decline, and mortality in patients with congestive heart failure. Physicians can assess depression by using the SIG E CAPS + mood mnemonic, or any of a number of easily administered and scored self-report inventories. Cognitive-behavior therapy is the preferred psychological treatment. Cognitive-behavior therapy emphasizes the reciprocal interactions among physiology, environmental events, thoughts, and behaviors, and how these may be altered to produce changes in mood and behavior. Pharmacologically, the selective serotonin reuptake inhibitors are recommended, whereas the tricyclic antidepressants are not recommended for depression in congestive heart failure patients. The combination of a selective serotonin reuptake inhibitor with cognitive-behavior therapy is often the most effective treatment.

AB - The prevalence rates of depression in congestive heart failure patients range from 24%-42%. Depression is a graded, independent risk factor for readmission to the hospital, functional decline, and mortality in patients with congestive heart failure. Physicians can assess depression by using the SIG E CAPS + mood mnemonic, or any of a number of easily administered and scored self-report inventories. Cognitive-behavior therapy is the preferred psychological treatment. Cognitive-behavior therapy emphasizes the reciprocal interactions among physiology, environmental events, thoughts, and behaviors, and how these may be altered to produce changes in mood and behavior. Pharmacologically, the selective serotonin reuptake inhibitors are recommended, whereas the tricyclic antidepressants are not recommended for depression in congestive heart failure patients. The combination of a selective serotonin reuptake inhibitor with cognitive-behavior therapy is often the most effective treatment.

UR - http://www.scopus.com/inward/record.url?scp=0042821891&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0042821891&partnerID=8YFLogxK

U2 - 10.1111/j.1527-5299.2003.01356.x

DO - 10.1111/j.1527-5299.2003.01356.x

M3 - Review article

C2 - 12826775

AN - SCOPUS:0042821891

VL - 9

SP - 163

EP - 169

JO - Prevention and Management of Congestive Heart Failure

JF - Prevention and Management of Congestive Heart Failure

SN - 1527-5299

IS - 3

ER -